Century Advances Diabetes Cell Therapy Toward Human Trials
PHILADELPHIA, PA — Century Therapeutics, Inc. (Nasdaq: IPSC) said it remains on track to seek regulatory clearance next year for its experimental type 1 diabetes cell therapy as the company …
Century Advances Diabetes Cell Therapy Toward Human Trials Read More